Patents by Inventor Jonathan L. Wright

Jonathan L. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
    Publication number: 20080242694
    Abstract: Provided herein are Heterocyclic Compounds having the following structure: wherein R1, R2, X, Y and Z are as defined herein, compositions comprising an effective amount of a Heterocyclic Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heterocyclic Compound to a patient in need thereof.
    Type: Application
    Filed: September 17, 2007
    Publication date: October 2, 2008
    Inventors: Neil R. D'Sidocky, Roy L. Harris, Sayee G. Hegde, Robert Hilgraf, Margaret A. McCarrick, Jeffrey A. McKie, Deborah S. Mortensen, Lisa Nadolny, Sophie M. Perin-Ninkovic, John J. Sapienza, Jonathan L. Wright
  • 4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
    Patent number: 6284774
    Abstract: Novel 4-Benzyl piperidine alkylsulfoxide heterocycles are disclosed and their use as subtype selective NMDA receptor antagonists, particularly for the treatment of Parkinson's disease, most preferably in combination with L-DOPA.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: September 4, 2001
    Assignee: Warner-Lambert Company
    Inventors: Jonathan L. Wright, Suzanne Ross Kesten, Ravindra B. Upasani, Nancy C. Lan
  • Sulfonylquinolines as central nervous system and cardiovascular agents
    Patent number: 5552411
    Abstract: Sulfonylquinolines are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antiobesity agents and for the treatment of hypertension.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: September 3, 1996
    Assignee: Warner-Lambert Company
    Inventors: Dennis M. Downing, Jonathan L. Wright
  • Benzimidazoles and imidazopyridines as central nervous system agents
    Patent number: 5486517
    Abstract: Benzimidazoles and imidazopyridines are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and for the treatment of disorders which respond to dopaminergic blockade including psychotis depression, substance abuse, and compulsive disorders.
    Type: Grant
    Filed: May 10, 1994
    Date of Patent: January 23, 1996
    Assignee: Warner-Lambert Company
    Inventors: Dennis M. Downing, Shelly A. Glase, Stephen J. Johnson, Lawrence D. Wise, Jonathan L. Wright
  • Dimeric benzimidazoles as central nervous system agents
    Patent number: 5414010
    Abstract: Dimeric benzimidazoles are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and for the treatment of disorders which respond to dopaminergic blockade including psychotic depression, substance abuse, and compulsive disorders.
    Type: Grant
    Filed: May 10, 1994
    Date of Patent: May 9, 1995
    Assignee: Warner-Lambert Company
    Inventors: Dennis M. Downing, Lawrence D. Wise, Jonathan L. Wright